Skip to main content
SpringerLink
Log in

Activated protein C: do more survive?

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mackenzie AF (2005) Activated protein C: do more survive? Intensive Care Med 31:1624–626

    Article  PubMed  Google Scholar 

  2. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709

    Article  PubMed  CAS  Google Scholar 

  3. Abraham E, Laterre P-F, Garg R, Levy H, Talwar D, Trzaskoma BL, François B, Guy JS, Brückmann M, Rea-Neto A, Rossaint R, Perrotin D, Sablotzki A, Arkins N. Utterback BG, Macias WL (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353:1332–1341

    Article  PubMed  CAS  Google Scholar 

  4. Angus DC, Laterre PF, Helterbrand J, Ball DE, Garg R, Bernard GR (2002) The effects of drotrecogin alfa (activated) on long-term survival after severe sepsis (abstract). Chest 122:51S

    Google Scholar 

  5. Angus DC, Laterre PF, Helterbrand J, Ely EW, Ball DE, Garg R, Weissfeld LA, Bernard GR for the PROWESS investigators (2004) The effect of drotrecogin alfa (activated) on long-term survival after severe sepsis. Crit Care Med 32:2199–2206

    Article  PubMed  CAS  Google Scholar 

  6. Assmann SF, Pocock SJ, Enos LE, Kasten LE (2000) Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 355:1064–1069

    Article  PubMed  CAS  Google Scholar 

  7. Yusuf S, Wittes J, Probstfield J, Tyroler HA (1991) Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 266:93–98

    Article  PubMed  CAS  Google Scholar 

  8. Slutsky AS, Lavery JV (2004) Data Safety and Monitoring Boards. N Engl J Med 350:1143–1147

    Article  PubMed  CAS  Google Scholar 

  9. Vincent JL, Angus DC, Artigas A, Kalil A, Basson BR, JAMAl HH, Johnson G 3rd, Recombinant Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group (2003) Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial. Crit Care Med. 31:834–840

    Article  PubMed  CAS  Google Scholar 

  10. Nick JA, Coldren DC, Geraci MW, Poch KR, Fouty BW, O'Brien J, Gruber M, Zarini S, Murphy RC, Kuhn K, Richter D, Kast KR, Abraham E (2004) Recombinant human activated protein C reduces human endotoxin-induced pulmonary inflammation via inhibition of neutrophil chemotaxis. Blood 15 104:3878–3885

    Google Scholar 

  11. Kalil AC, Coyle SM, Um JY, LaROsa SP, Turlo MA, Calvano SE, Sundin DP, Nelson DR, Lowry SF (2004) Effects of drotrecogin alfa (activated) in human endotoxemia. Shock 21:222–229

    Article  PubMed  CAS  Google Scholar 

  12. Macias WL, Yan SB, Williams MD, Um SL, Sandusky GE, Ballard DW, Planquois JM (2005) New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated) Crit Care 4:S38–S45

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA

    William L. Macias

Authors
  1. William L. Macias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William L. Macias.

Additional information

This comment refers to the contribution available at: http://dx.doi.org/10.1007/s00134-006-0090-0

Rights and permissions

Reprints and permissions

About this article

Cite this article

Macias, W.L. Activated protein C: do more survive?. Intensive Care Med 32, 605–607 (2006). https://doi.org/10.1007/s00134-006-0087-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-006-0087-8

Keywords

Search

Navigation